Skip to main navigation Skip to search Skip to main content

P553 Active tuberculosis and opportunistic infections: Pooled safety analysis of ustekinumab through up to 5 years across all approved indications

  • Subrata Ghosh
  • , Millie Long
  • , Elyssa Ott
  • , Christopher Gasink
  • , Thomas Baker
  • , B. Goodwin
  • , Ye Miao
  • , Edward V. Loftus
  • University of North Carolina at Chapel Hill
  • Janssen Scientific Affairs, LLC
  • Mayo Clinic Rochester, MN

Research output: Contribution to journal › Meeting abstract › peer-review

Search results